about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOn the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringEpidemiology of medications use in pregnancyDesigning drug trials: considerations for pregnant women.Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in PregnancyPhysiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.Treatment with antipsychotics in pregnancy: Changes in drug disposition.Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation.Industry Perspective of Drug Development for Pregnant/Breastfeeding Women.Pharmacokinetics of clomipramine during pregnancy.Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model.Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated malaria
P2860
Q26766128-3A736FF6-7FBE-4EFD-B934-DB3F409CB5FEQ27024074-F14B1E46-D5FC-4347-BF6A-B6F00BC13677Q28083692-9D4AC25C-22F7-40D0-B72A-070FBA9879C4Q34999905-AA9148E1-B13F-47EC-A19A-92572BED9C34Q35797203-99C39BCC-7E83-4F1D-BDDA-E16C69234943Q36243626-CC544140-AC0C-43CC-944D-62D6E91AB9CBQ36635719-89249C40-DE1D-4BFA-B512-AB8A8ED90F29Q38712679-17B07B7B-181C-48A1-A12C-258E6BB21A82Q38802632-A8F9C86C-D836-49DB-A13E-BED3B44468B3Q39805320-38FAE281-1C5A-47B4-840D-35EF2368BDD6Q39848038-38CDA127-E32B-4B14-812E-60A6FAC0BE96Q40489805-E47C57A2-CE27-418C-8815-CF5122D6AC0BQ41469292-2EBB4175-2CA6-4EE7-9D72-9AB0812ABF11Q41678423-0CA94644-334B-4300-99C6-B3F171EED70CQ47724161-DD27814C-1802-483C-9A00-93B3BB37A602Q47963328-EDE26A1D-BBB2-4CEA-8F13-A125B3A5C0B0Q48072950-9CEFA9ED-E2BB-4743-82B9-AA9045890D7BQ49631079-1721D35B-BDEC-4F0E-900F-191E4D1B1E80Q56354961-4FAA5709-8692-4EE0-B32C-DE471B51439A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacometrics in pregnancy: An unmet need.
@en
type
label
Pharmacometrics in pregnancy: An unmet need.
@en
prefLabel
Pharmacometrics in pregnancy: An unmet need.
@en
P2093
P1476
Pharmacometrics in pregnancy: An unmet need.
@en
P2093
Alice Ban Ke
Amin Rostami-Hodjegan
Jashvant D Unadkat
P356
10.1146/ANNUREV-PHARMTOX-011613-140009
P577
2014-01-01T00:00:00Z